Corcept Therapeutics Receives US FDA Approval for Ovarian Cancer Drug
The US Food and Drug Administration (FDA) has approved Corcept Therapeutics’ relacorilant for the treatment of platinum-resistant epithelial ovarian cancer. […]
US-FDA-APPROVAL
GSK Receives US FDA Approval for Expanded Use of RSV Vaccine Arexvy
GSK has received approval from the US Food and Drug Administration (FDA) for the expanded use of its respiratory syncytial […]
